Kannagi Chinnakannu

Suggest Changes
Learn More
20038 Background: Prostate cancer (CaP) that relapses following androgen-ablation therapy is hormone refractory, yet its growth continues to depend on androgen receptor (AR). Therefore, a curative(More)
  • 1